Clinical trial
Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and…
NCT00225394 · University of Massachusetts, Worcester, Other · Completed
Key facts
| NCT number | NCT00225394 |
|---|---|
| Title | Long Term Use of Valganciclovir for Prophylaxis of CMV Disease in Kidney and Pancreas Transplant Patients |
| Official title | Long-Term Valcyte Therapy in Transplant Patients and the Development of Ganciclovir Resistant CMV |
| Lead sponsor | University of Massachusetts, Worcester, Other |
| Collaborators | Beth Israel Deaconess Medical Center Lahey Clinic Rhode Island Hospital |
| Status | Completed |
| Study type | Observational |
| Conditions | CMV Disease, Viral Resistance, Rejection, Death |
| Enrollment | 100 |
| Start date | Oct 1, 2003 |
| Completion | Jul 1, 2006 |
| First posted | Sep 23, 2005 |
| Last update posted | Sep 23, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: